Inside, during or after a meal. Special training and diet is not required.
The drug is intended for use in adults and children aged 1 year.
The dose of the drug is set individually, depending on the type of infestation and body weight of the patient. The need to reduce the dose from 400 mg to 200 mg may occur if the child's body weight is less than 10 kg. However, in general, there are no grounds for reducing the dose in children.
The maximum daily dose is 800 mg.
Children should, if possible, avoid using high doses of albendazole for a long time.
It is recommended to use a syringe for accuracy and convenience of dosing.
With nematodes (including ascaridosis, trichocephalosis, non-caranose)
The standard dose for the treatment of invasion by roundworms for adults and children with weight body 60 kg and more - 400 mg (20 ml of suspension) per day once;
for adults and children weighing less than 60 kg -15 mg / kg body weight once;
For children aged 1 to 2 years, a dose of 200 mg (10 ml of suspension) should be used.
With enterobiasis adults and children older than 2 years take 400 mg (20 ml suspension) once; for children aged 1 to 2 years, a dose of 200 mg (10 ml suspension) once.
If necessary, after 14 days, repeat the course of treatment in the same dose and in the same regime.
With strongyloidiasis. ankylostomidosis adults and children older than 2 years take 400 mg (20 ml of suspension) once for 3 days. For children from 1 year to 2 years, the dose is 200 mg (10 ml suspension). After a week, it is recommended to repeat the treatment cycle in the same doses.
With trichinosis the drug is taken 400 mg (20 ml suspension) 2 times a day for 10-14 days. In case of severe invasion and organ damage (myocarditis, pneumonitis, meningoencephalitis), glucocorticosteroid and symptomatic agents are also taken.
With toxocarose adults and children older than 14 years with a body weight of 60 kg or more: take 400 mg (20 ml of suspension) 2 times a day for 10 days; adult patients with a body weight of less than 60 kg 200 mg (10 ml suspension) 2 times a day for 10 days; children 2-14 years: take 10 mg / kg 2 times a day for 10 days. It is required to conduct repeated courses of treatment with an interval of 2 weeks / month. In the process of treatment, peripheral blood control (once every 5-7 days) and aminotransferases at the same time is necessary.
With giardiasis: 400 mg I once a day for 3 days. Children with body weight less than 10 kg 200 mg once a day once for 5 days.
With mixed invasions the drug is taken 400 mg twice a day, for 3 days. If necessary, the course of treatment can be repeated after 1 month.
With neurocysticercosis and hydatidid echinococcosis patients with a body weight of 60 kg or more take 400 mg (20 ml of suspension) twice a day, with a body weight of less than 60 kg - at a rate of 15 mg / kg body weight per day in 2 divided doses; the maximum daily dose of 800 mg. The course of treatment for neurocysticercosis 28-30 days (2 days before the drug and in the first week of taking glucocorticosteroid drugs), with echinococcosis - 3 cycles of 28 days with a 14 day break between cycles.
Before using the drug, you need a clinical blood test and a biochemical blood test. Treatment is carried out at normal laboratory parameters. In the process of treatment, a blood and aminotransferase assay is performed every 5-7 days.
With a decrease in white blood cells lower 3.0x109 and a 2-fold increase in the activity of aminotransferases, it is necessary to suspend treatment until the parameters are normalized.
The drug therapy can be resumed after the laboratory indicators return to the level that was before the start of therapy, however, during the therapy laboratory tests should be carried out regularly.
The appointment of hepatoprotectors during treatment and in cases of toxic manifestations is ineffective, it is necessary to cancel the drug.
Treatment albendazole alveolar echinococcosis is an additional remedy.
Doses and the mode of prescribing the drug are the same as for hydatidid echinococcosis. The duration and course of treatment is determined by the patient's condition and tolerability of the drug.